Clinical Trial Update: Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

View source ↗

Summary

A completed study investigating the impact of gut and intratumoral microbiomes on chemo-induced immune responses in patients with triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Triple Negative Breast Cancer | Status: COMPLETED